Holen Sie sich die Stockscreener-App
1.51
11.44%
-0.195
Handel nachbörslich:
1.55
0.04
+2.65%
Schlusskurs vom Vortag:
$1.705
Offen:
$1.71
24-Stunden-Volumen:
421.66K
Relative Volume:
1.70
Marktkapitalisierung:
$79.59M
Einnahmen:
$1.82M
Nettoeinkommen (Verlust:
$-267.63M
KGV:
-0.0749
EPS:
-20.1639
Netto-Cashflow:
$-50.53M
1W Leistung:
-22.56%
1M Leistung:
-11.70%
6M Leistung:
-8.48%
1J Leistung:
-35.47%
1-Tages-Spanne:
$1.46
$1.7282
1-Wochen-Bereich:
$1.46
$2.04
52-Wochen-Spanne:
$1.09
$3.40
Cibus Inc Stock (CBUS) Company Profile
Firmenname
Cibus Inc
Sektor
Branche
Telefon
(858) 450-0008
Adresse
6455 NANCY RIDGE DRIVE, SAN DIEGO
Vergleichen Sie CBUS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.51 | 89.87M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.14 | 112.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.33 | 77.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
816.37 | 50.10B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
365.46 | 46.97B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
341.64 | 36.99B | 4.98B | 69.59M | 525.67M | 0.5197 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
| 2023-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
Cibus Inc Aktie (CBUS) Neueste Nachrichten
Quarterly Risk: Is Cibus Inc forming bullish engulfing patternsWeekly Profit Summary & Weekly Return Optimization Plans - baoquankhu1.vn
Cibus, Inc. (NASDAQ:CBUS) Short Interest Up 32.4% in December - MarketBeat
Institution Moves: How is Cibus Inc managing supply chain issuesLayoff News & Technical Buy Zone Confirmations - baoquankhu1.vn
Cibus' Agri-Bio GambleTechnology Is Promising, Cash Is Limited, Execution Is Key - Seeking Alpha
Cibus elects Wichner to board of directors - MSN
What technical charts say about Cibus Inc. stockMarket Performance Recap & Detailed Earnings Play Alerts - ulpravda.ru
Why Cibus Inc. stock is a must watch in 2025Weekly Market Outlook & Short-Term Swing Trade Alerts - Улправда
Will Cibus Inc. stock maintain dividend yieldJuly 2025 Trends & High Win Rate Trade Tips - ulpravda.ru
Is Cibus Inc. stock attractive for long term wealth buildingSwing Trade & Fast Entry High Yield Stock Tips - Улправда
Why Cibus Inc. stock attracts global investorsWeekly Stock Analysis & Free Weekly Chart Analysis and Trade Guides - Улправда
CIBUS INC (CBUS) Stock Technical Analysis - Chartmill
Cibus repurchases shares from employee in board-approved transaction By Investing.com - Investing.com India
Cibus repurchases shares from employee in board-approved transaction - Investing.com
Cibus executes minor internal Class A share repurchase - TipRanks
Cibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin America - AgriBusiness Global
Retail Trends: Why Cibus Inc stock is a must watch in 2025Weekly Market Outlook & Daily Profit Maximizing Tips - moha.gov.vn
Cibus and Interoc sign LOI for herbicide-tolerant rice in Latin America By Investing.com - Investing.com South Africa
Cibus, Inc. (NASDAQ:CBUS) surges 15%; individual investors who own 43% shares profited along with insiders - Yahoo Finance
Cibus and Interoc sign LOI for herbicide-tolerant rice in Latin America - Investing.com Canada
Cibus (CBUS) and Interoc Plan Commercialization of Herbicide-Tol - GuruFocus
Cibus and Interoc Advance Rice Commercialization Strategy - GlobeNewswire
Retail investors invested in Cibus, Inc. (NASDAQ:CBUS) up 11% last week, insiders too were rewarded - simplywall.st
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), UCB SA (GB:0NZT) and Cibus (CBUS) - The Globe and Mail
Cibus director Prante Gerhard sells $2,875 in stock - MSN
Short Interest in Cibus, Inc. (NASDAQ:CBUS) Decreases By 32.9% - MarketBeat
Stock Market Recap: Why Cibus Inc stock is a must watch in 20252025 Volatility Report & Verified Short-Term Plans - moha.gov.vn
Will Cibus Inc. stock pay special dividendsWeekly Profit Summary & Long-Term Capital Growth Ideas - Улправда
Can Cibus Stock Hold Up When Markets Turn? - Trefis
Cibus (CBUS) EV-to-OCF : -1.87 (As of Dec. 19, 2025) - GuruFocus
How Cibus Inc. stock responds to policy changesJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - Улправда
Craig Wichner Net Worth (2025) - GuruFocus
Will Cibus Inc. stock attract more institutional investorsEarnings Beat & Short-Term Trading Alerts - bolumsonucanavari.com
Guidance Update: Is Cibus Inc. stock recession proof2025 Trade Ideas & High Conviction Buy Zone Picks - Улправда
Is Cibus Inc. stock recession proof2025 Bull vs Bear & Weekly Market Pulse Alerts - Улправда
Gratia Capital LLC Acquires New Shares in Cibus, Inc. $CBUS - MarketBeat
Cibus director Prante sells $2,875 in stock - MSN
Signal Recap: Can Cibus Inc stock maintain growth trajectory2025 Macro Impact & Weekly Return Optimization Alerts - moha.gov.vn
CBUS FinancialsIncome Statement - Quiver Quantitative
Cibus (CBUS) Applauds EU Agreement on Gene-Edited Plant Regulati - GuruFocus
Cibus Welcomes EU Political Agreement on New Genomic Techniques, Supporting Advances in Plant Breeding Innovation - Quiver Quantitative
Cibus (Nasdaq: CBUS) sees EU NGT agreement advancing gene-edited plant rules - Stock Titan
Cibus Welcomes the Positive Conclusion of Trilogue - GlobeNewswire
Canaccord Genuity Remains a Buy on Cibus (CBUS) - The Globe and Mail
Cibus’ (CBUS) “Buy” Rating Reaffirmed at Canaccord Genuity Group - Defense World
Is Cibus Stock Built to Withstand a Pullback? - Trefis
Canaccord Genuity Maintains Cibus (CBUS) Buy Recommendation - Nasdaq
Cibus (CBUS) Stock Rating Maintained at "Buy" by Canaccord Genui - GuruFocus
Cibus (NASDAQ:CBUS) Earns "Buy" Rating from Canaccord Genuity Group - MarketBeat
ETFs Investing in Cibus, Inc. Stocks - TradingView — Track All Markets
What drives Cibus Inc stock priceStock Valuation Metrics & Free High Frequency Trading Ideas - earlytimes.in
Finanzdaten der Cibus Inc-Aktie (CBUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.17%
4.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):